Therapeutic agent for threatened abortion

Details Therapeutic agent for threatened abortion Therapeutic agent for threatened abortion

1994-12-23

1996-09-10

Chan, Christina Y.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514210, 530381, A61K 3516, A61K 3550, A61K 3843, A61K 2600

Patent

active

055545939

ABSTRACT:
Therapeutic agent for threatened abortion which contains human blood coagulation factor XIII as the active ingredient. Human blood coagulation factor XIII administered to patients with threatened abortion successfully treats the disease, and its effects are marked.

REFERENCES:
patent: 4327086 (1982-04-01), Fukushima et al.
patent: 5164373 (1992-11-01), Shikano et al.
Duckert, F., "Fibuiu Stabelizing Factor, Factor XIII", BLUT, 26(3)pp. 177-179 (1973) Abstract.
M. Mahi, "Hemostasis and Thrombosis in Obstetrics and Gynecology," Chapt 4, Die Medizinische Verlagsgellschaft mbH, (1991) pp. 78-92.
Schuling et al. "Fibrolinosys . . . Spont. Abortion Eur. J. Obstet. Gynecol Repnod Biol" (2-3) 1990 215-22 (abstract).
Adany & Muszbek, "Immunohistochemical Detection . . . in Human Uterus Histochemistry" '91 (2) 1989 pp. 169-174 (abstract).

Affiliated with

Also associated with

Rating

Therapeutic agent for threatened abortion does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agent for threatened abortion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for threatened abortion will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1320431